SUMMARY: The effect of lymphocytosis-promoting factor (LPF) on antibody response in mice was estimated under different sets of experimental conditions. Four-and 6-week-old mice were intravenously inoculated with LPF. Three days later these mice were inoculated either intraperitoneally or intravenously with sheep red blood cell (SRBC) or human serum albumin (HSA) as an antigen.
Several reports have shown that LPF of Bordetella pertussis acts as an immunomodulator in humoral and cellular immunity. In these reports, however, conflicting results were given in respect to the effect of LPF on antibody response in mice. Asakawa (1969) demonstrated that antibody response of mice to SRBC and tetanus toxoid was suppressed by inoculation of LPF prior to the antigen, whereas some other workers observed an increased antibody response when LPF was mixed with the antigen or given before the administration of antigen. It is possible that the above contradictions may have been due to some different experimental conditions used by them. To test this possibility, we compared the erect of LPF on antibody response in mice under several different sets of well-defined experimental conditions. The LPF preparation used had been partially purified by the method de-scribed previously (Iwasa et al., 1968) . The preparation had high activities of LPF and histamine-sensitizing factor (HSF) as well; it contained little, if any, endotoxic activity. Either SRBC or HSA was used as an antigen. Conventionallybred female mice (ddY-Shizuoka), 4 and 6 weeks old, were inoculated intravenously with LPF in a dose of 0.84 LPUp * of which lymphocytosis-promoting activity was comparable to those of doses used in our earlier work (Asakawa, 1969) . Other mice given no LPF were served as control. Three days later these mice were immunized with an antigen intraperitoneally or intravenously and, thereafter, followed up for antibody response. Blood in an amount of 0.1 ml was taken from the left and the right retroorbital sinus alternatively at intervals of at least 7 days. The blood was diluted in 0.9 ml of saline for assaying anti-SRBC titer or in 0.4 ml for anti-HSA and allowed to coagulate overnight in a refregerator. The retroorbital serums thus obtained were stored at -20 C until used for antibody titration. Hemagglutinin was titrated by the method described (Asakawa, 1969) . Anti-HSA titer was determined by passive hemagglutination with glutaraldehyde-fixed mouse red cells sensitized with HSA by the aid of tannic acid (Bing, weyand and Stavitsky, 1967; Kawaguchi, 1971) . The reaction was allowed to proceed on microtiter plates with barbital buffer (pH 7.2) containing 1% heat-inactivated mouse serum as diluent. Retroorbital serums were inactivated at 56 C for 30 min prior to titration. Antibody titers were transformed into logarithm. A value of 5 was provisionally given to the titer of retroorbital serum showing negative anti-SRBC with undiluted serum, while a value of 2.5 was arbitrarily given to that showing negative anti-HSA with that. Significance tests were made at a probability level of p=0.05. As the first step, the effect of LPF on anti-SRBC response was compared between 4-and 6-week-old mice (Fig. 1) . A markedly increased hemagglutinin production was demonstrated in 6-week-old mice by inoculating with LPF when the antigen was injected intraperitoneally (Fig, la) . Such a level of hemagglutinin production was also detectable in 6-week-old mice given LPF in a dose as low as 0.21 LPUp but not in a dose of 0.05 (data not shown). On the other hand, these 6-week-old mice responded to intravenously inoculated SRBC without any appreciable effect of LPF; no significant difference in hemagglutinin response was detectable between LPF-treated and -untreated mice (Fig. lc) . In 4-week-old mice, unlike 6-week-old ones, the administration of LPF failed to enhance hemagglutinin production in response to the intraperitoneally inoculated antigen (Fig. lb) . In addition, when SRBC was injected intravenously, the antibody * 21 units of lymphocytosis-promoting activity (LPU p) have been assigned arbitrarily to a reference LPF preparation in this laboratory (Kurokawa et al., 1978) . The activity of any preparation of LPF was determined relative to the reference by the parallel line assay method (Finney, 1964 response was rather suppressed by the inoculation of LPF (Fig. id) ; a decreased hemagglutinin production was observed as compared with that in mice given no LPF, in exact accordance with the previous findings obtained under similar experimental conditions (Asakawa, 1969) . Such a suppressive effect of LPF was not detectable, however, in a dose as low as 0.21 LPUp (data not shown) . 4-week-old as well as 6-week-old mice. LPF-treated 6-week-old mice, however, induced an increased antibody production regardless of the route of antigen administration (Fig. 2a, 2c) . LPF-treated 4-week-old mice responded to the intraperitoneally inoculated antigen in a degree much the same as did the LPFtreated 6-week-old mice (Fig. 2b) , while producing a detectable but fairly low anti-HSA response to the intravenously inoculated one (Fig. 2d) . When LPF was reduced to 0.21 LPUp, not only 6-week-old but also 4-week-old mice responded to HSA inoculated intraperitoneally or intravenously with an increased antibody production to the same extent as did 6-week-old mice given LPF in a dose of 0.84 LPUp (data not shown). These findings collectively indicate that the conflicting results reported on the effect of LPF on antibody response in mice should be interpreted from the different experimental conditions used by different workers. The workers who reported an adj uvant effect of LPF on antibody response did use mice of ages 8 to 10 weeks for immunization and adopted the ip route for antigen administration (Lehrer, Vangham and Tan, 1975a,b; Sato, 1976; Kamiyama, Sato and Sato, 1976) , while Asakawa (1969) who observed a rather suppressive effect did use 4-week-old mice and adopted the iv route for antigen administration.
